Brief: Cumberland - In Early Sept., Clinigen & Co Completed Amendment To Agreement Whereby Transition Date Has Changed To Dec. 31, 2019

Cumberland Pharmaceuticals

11/09/2019 22:23

Sept 11 (Reuters) - Cumberland Pharmaceuticals Inc  CPIX.O :
    * CUMBERLAND - IN EARLY SEPT., CLINIGEN & CO COMPLETED
AMENDMENT
TO AGREEMENT WHEREBY TRANSITION DATE HAS CHANGED TO DEC. 31,
2019
    * CUMBERLAND - WILL NO LONGER DISTRIBUTE ETHYOL OR TOTECT
AFTER
TRANSITION DATE, RECEIVE $5 MILLION IN FINANCIAL CONSIDERATION
FROM CLINIGEN OVER 2-YEAR PERIOD

Source text for Eikon: https://bit.ly/2kheHmC
Further company coverage:  CPIX.O 

 ((Briefs@thomsonreuters.com;))